Suivre
Su Mi Choi
Su Mi Choi
AstraZeneca
Adresse e-mail validée de medimmune.com
Titre
Citée par
Citée par
Année
Efficient drug screening and gene correction for treating liver disease using patient‐specific stem cells
SM Choi, Y Kim, JS Shim, JT Park, RH Wang, SD Leach, JO Liu, C Deng, ...
Hepatology 57 (6), 2458-2468, 2013
2702013
Reduction of hypoxia-induced transcription through the repression of hypoxia-inducible factor-1α/aryl hydrocarbon receptor nuclear translocator DNA binding by the 90-kDa heat …
E Hur, HH Kim, SM Choi, JH Kim, S Yim, HJ Kwon, Y Choi, DK Kim, ...
Molecular pharmacology 62 (5), 975-982, 2002
1732002
Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells
SM Choi, H Liu, P Chaudhari, Y Kim, L Cheng, J Feng, S Sharkis, Z Ye, ...
Blood, The Journal of the American Society of Hematology 118 (7), 1801-1805, 2011
1082011
Stra13/DEC1 and DEC2 inhibit sterol regulatory element binding protein-1c in a hypoxia-inducible factor-dependent mechanism
SM Choi, HJ Cho, H Cho, KH Kim, JB Kim, H Park
Nucleic acids research 36 (20), 6372-6385, 2008
772008
Clioquinol, a Cu (II)/Zn (II) chelator, inhibits both ubiquitination and asparagine hydroxylation of hypoxia-inducible factor-1α, leading to expression of vascular endothelial …
SM Choi, KO Choi, YK Park, H Cho, EG Yang, H Park
Journal of biological chemistry 281 (45), 34056-34063, 2006
742006
Liver engraftment potential of hepatic cells derived from patient-specific induced pluripotent stem cells
SM Choi, Y Kim, H Liu, P Chaudhari, Z Ye, YY Jang
Cell cycle 10 (15), 2423-2427, 2011
622011
Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer
B Kumar, AZ Rosenberg, SM Choi, K Fox-Talbot, AM De Marzo, L Nonn, ...
Scientific reports 8 (1), 7189, 2018
482018
Inhibition of the MEK-1/P42 MAP kinase reduces aryl hydrocarbon receptor–DNA interactions
S Yim, M Oh, SM Choi, H Park
Biochemical and biophysical research communications 322 (1), 9-16, 2004
382004
Insulin and hypoxia share common target genes but not the hypoxia-inducible factor-1α
S Yim, SM Choi, Y Choi, N Lee, J Chung, H Park
Journal of Biological Chemistry 278 (40), 38260-38268, 2003
382003
PDCD4 is an androgen-repressed tumor suppressor that regulates prostate cancer growth and castration resistance
K Zennami, SM Choi, R Liao, Y Li, W Dinalankara, L Marchionni, ...
Molecular Cancer Research 17 (2), 618-627, 2019
352019
Microarray analyses of hypoxia‐regulated genes in an aryl hydrocarbon receptor nuclear translocator (Arnt)‐dependent manner
SM Choi, H Oh, H Park
The FEBS journal 275 (22), 5618-5634, 2008
262008
The zinc chelator, N,N,N′,N′-tetrakis (2-pyridylmethyl) ethylenediamine, increases the level of nonfunctional HIF-1α protein in normoxic cells
SM Choi, KO Choi, N Lee, M Oh, H Park
Biochemical and biophysical research communications 343 (4), 1002-1008, 2006
262006
Chenodeoxycholic acid reduces hypoxia inducible factor-1α protein and its target genes
Y Moon, SM Choi, S Chang, B Park, S Lee, MO Lee, HS Choi, H Park
PloS one 10 (6), e0130911, 2015
132015
The novel peptide F29 facilitates the DNA-binding ability of hypoxia-inducible factor-1α
SM Choi, HS Park
BMB reports 42 (11), 737-742, 2009
52009
Applications of human induced pluripotent stem cell derived hepatocytes
H Liu, P Chaudhari, SM Choi, YY Jang
Stem Cells and Cancer Stem Cells, Volume 3: Stem Cells and Cancer Stem Cells …, 2012
22012
Multistage hepatic differentiation from human induced pluripotent stem cells
SM Choi, H Liu, Y Kim, YY Jang
Human Embryonic and Induced Pluripotent Stem Cells: Lineage-Specific …, 2012
22012
a Cu (II)/Zn (II) chelator inhibits both ubiquitination and asparagine hydroxylation of HIF-1alpha, leading to expression of VEGF and EPO in normoxic cells
SM Choi, KO Choi, YK Park, H Cho, EG Yang, HC Park
J Biol Chem 281, 34056-34063, 2006
22006
Aryl hydrocarbon receptor nuclear translocator is involved in ATP homeostasis in both normoxic and hypoxic monolayer mouse hepatoma cells
SM Choi, HS Park
Biomolecules & Therapeutics 14 (3), 132-136, 2006
12006
Drug discovery using human ipsc based disease models and functional hepatic cells
SM Choi, Y Kim, YY Jang
Stem Cells and Cancer Stem Cells, Volume 10: Therapeutic Applications in …, 2013
2013
Generation of Human Induced Pluripotent Stem Cells from Endoderm Origin Cells
H Liu, SM Choi, YY Jang
Human Embryonic and Induced Pluripotent Stem Cells: Lineage-Specific …, 2012
2012
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20